Expression of parvalbumin and glutamic acid decarboxylase-67 after acute administration of MK-801. Implications for the NMDA hypofunction model of schizophrenia

Psychopharmacology

Volumn 217, Issue 2, 2011, Pages 231-238

  Romón, Tamara ^a,b   Mengod, Guadalupe ^a,c   Adell, Albert ^a,b  

^a INST D INVESTIGACIONS B   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Animal model; GAD 67; Hippocampus; MK 801; NMDA antagonism; Parvalbumin; Prefrontal cortex; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; BINDING PROTEIN; DIZOCILPINE; GLUTAMATE DECARBOXYLASE 67; ISOENZYME; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PARVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; BRAIN REGION; BRAIN TISSUE; CADAVER; CALCIUM BINDING; CONTROLLED STUDY; DENTATE GYRUS; DRUG MECHANISM; ENTORHINAL CORTEX; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORBITAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHIZOPHRENIA;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; GLUTAMATE DECARBOXYLASE; IN SITU HYBRIDIZATION; MALE; PARVALBUMINS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 82955198467     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2268-6     Document Type: Article

References (56)

1. Abekawa T, Honda M, Ito K, Koyama T (2003) Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and α1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats. Psychopharmacology Berl 169:247-256 (Pubitemid 37255517)
2. Akbarian S, Huang HS (2006) Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res Brain Res Rev 52:293-304 (Pubitemid 44291805)
3. Arai R, Jacobowitz DM, Deura S (1994) Distribution of calretinin, calbindin-D28k, and parvalbumin in the rat thalamus. Brain Res Bull 33:595-614 (Pubitemid 24079478)
4. Bartos M, Vida I, Jonas P (2007) Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci 8:45-56 (Pubitemid 46011998)
5. Beasley CL, Zhang ZJ, Patten I, Reynolds GP (2002) Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol Psychiatry 52:708-715
6. Benes FM, Berretta S (2001) GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25:1-27 (Pubitemid 32493819)
7. Braun I, Genius J, Grunze H, Bender A, Moller HJ, Rujescu D (2007) Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism. Schizophr Res 97:254-263 (Pubitemid 350088379)
8. Celio MR (1990) Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience 35:375-475 (Pubitemid 20176750)
9. Cho RY, Ford JM, Krystal JH, Laruelle M, Cuthbert B, Carter CS (2005) Functional neuroimaging and electrophysiology biomarkers for clinical trials for cognition in schizophrenia. Schizophr Bull 31:865-869 (Pubitemid 41437779)
10. Cochran SM, Fujimura M, Morris BJ, Pratt JA (2002) Acute and delayed effects of phencyclidine upon mRNA levels of markers of glutamatergic and GABAergic neurotransmitter function in the rat brain. Synapse 46:206-214 (Pubitemid 35155173)
11. Cochran SM, Kennedy M, McKerchar CE, Steward LJ, Pratt JA, Morris BJ (2003) Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs. Neuropsychopharmacology 28:265-275
12. Coleman LG Jr, Jarskog LF, Moy SS, Crews FT (2009) Deficits in adult prefrontal cortex neurons and behavior following early post-natal NMDA antagonist treatment. Pharmacol Biochem Behav 93:322-330
13. Corbett R, Camacho F, Woods AT (1995) Antipsychotic agents antagonize non-competitive N-methyl-d-aspartate antagonistinduced behaviors. Psychopharmacology 120:67-74
14. Csillik B, Mihaly A, Krisztin-Peva B, Chadaide Z, Samsam M, Knyihar-Csillik E, Fenyo R (2005) GABAergic parvalbuminimmunoreactive large calyciform presynaptic complexes in the reticular nucleus of the rat thalamus. J Chem Neuroanat 30:17-26 (Pubitemid 40943565)
15. De Felipe J (1997) Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex. J Chem Neuroanat 14:1-19 (Pubitemid 28051036)
16. Esclapez M, Tillakaratne NJ, Kaufman DL, Tobin AJ, Houser CR (1994) Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. J Neurosci 14:1834-1855 (Pubitemid 24080030)
17. 65 and GAD67 mRNAs suggest that the two glutamate decarboxylases play distinctive functional roles. J Neurosci Res 34:689-706 (Pubitemid 23150329)
18. Freund TF, Buzsaki G (1996) Interneurons of the hippocampus. Hippocampus 6:347-470 (Pubitemid 126682925)
19. Gritti I, Manns ID, Mainville L, Jones BE (2003) Parvalbumin, calbindin, or calretinin in cortically projecting and GABAergic, cholinergic, or glutamatergic basal forebrain neurons of the rat. J Comp Neurol 458:11-31 (Pubitemid 36255324)
20. Grunze HCR, Rainnie DG, Hasselmo ME, Barkai E, Hearn EF, McCarley RW, Greene RW (1996) NMDA-dependent modulation of CA1 local circuit inhibition. J Neurosci 16:2034-2043 (Pubitemid 26144016)
21. Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, Sampson AR, Lewis DA (2003) Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 23:6315-6326 (Pubitemid 36875633)
22. Hof PR, Glezer II, Condé F, Flagg RA, Rubin MB, Nimchinsky EA, Vogt Weisenhorn DM (1999) Cellular distribution of the calciumbinding proteins parvalbumin, calbindin, and calretinin in the neocortex of mammals: phylogenetic and developmental patterns. J Chem Neuroanat 6:77-116 (Pubitemid 29155497)
23. Jackson ME, Homayoun H, Moghaddam B (2004) NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proc Natl Acad Sci USA 101:8467-8472 (Pubitemid 38736598)
24. Jodo E, Suzuki Y, Katayama T, Hoshino KY, Takeuchi S, Niwa SI, Kayama Y (2005) Activation of medial prefrontal cortex by phencyclidine is mediated via a hippocampo-prefrontal pathway. Cereb Cortex 15:663-669 (Pubitemid 40577482)
25. Kawaguchi Y, Kubota Y (1993) Correlation of physiological subgroupings of nonpyramidal cells with parvalbumin- and calbindinD28k-immunoreactive neurons in layer V of rat frontal cortex. J Neurophysiol 70:387-396 (Pubitemid 23220322)
26. Kemppainen S, Pitkänen A (2000) Distribution of parvalbumin, calretinin, and calbindin-D(28k) immunoreactivity in the rat amygdaloid complex and colocalization with gammaaminobutyric acid. J Comp Neurol 426:441-467
27. Korotkova T, Fuchs EC, Ponomarenko A, von Engelhardt J, Monyer H (2010) NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory. Neuron 68:557-569
28. Krystal JH, D'Souza DC, Mathalon D, Perry E, Belger A, Hoffman R (2003) NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology 169:215-233 (Pubitemid 37264943)
29. Laprade N, Soghomonian JJ (1995) MK-801 decreases striatal and cortical GAD65 mRNA levels. Neuroreport 6:1885-1889
30. Lewis DA, González-Burgos G (2008) Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 33:141-165 (Pubitemid 350191315)
31. Lewis DA, Hashimoto T, Volk DW (2005) Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6:312-324 (Pubitemid 40469985)
32. Li Q, Clark S, Lewis DW, Wilson WA (2002) NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: a potential mechanism of neurotoxicity. J Neurosci 22:3070-3080 (Pubitemid 35379196)
33. López-Gil X, Babot Z, Amargós-Bosch M, Suñol C, Artigas F, Adell A (2007) Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial refrontal cortex of the rat. Neuropsychopharmacology 32:2087-2097 (Pubitemid 47417703)
34. Markram H, Toledo-Rodriguez M, Wang Y, Gupta A, Silberberg G, Wu C (2004) Interneurons of the neocortical inhibitory system. Nat Rev Neurosci 5:793-807 (Pubitemid 39336216)
35. McDonald AJ, Mascagni F (2001) Colocalization of calcium-binding proteins and GABA in neurons of the rat basolateral amygdala. Neuroscience 105:681-693 (Pubitemid 32769832)
36. Meyer-Lindenberg AS, Olsen RK, Kohn PD, Brown T, Egan MF, Weinberger DR, Berman KF (2005) Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia. Arch Gen Psychiatry 62:379-386 (Pubitemid 40471687)
37. Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921-2927 (Pubitemid 27155025)
38. Morrow BA, Elsworth JD, Roth RH (2007) Repeated phencyclidine in monkeys results in loss of parvalbumin-containing axo-axonic projections in the prefrontal cortex. Psychopharmacology Berl 192:283-290 (Pubitemid 46669209)
39. Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998-1007
40. Pompeiano M, Palacios JM, Mengod G (1992) Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J Neurosci 12:440-453
41. Qin ZH, Zhang SP, Weiss B (1994) Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain. Brain Res Mol Brain Res 21:293-302 (Pubitemid 24038497)
42. Rujescu D, Bender A, Keck M, Hartmann AM, Ohl F, Raeder H, Giegling I, Genius J, McCarley RW, Moller HJ, Grunze H (2006) A pharmacological model for psychosis based on N-methyl-Daspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol Psychiatry 59:721-729
43. Sharp FR, Tomitaka M, Bernaudin M, Tomitaka S (2001) Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia? Trends Neurosci 24:330-334 (Pubitemid 32455433)
44. Soghomonian JJ, Martin DL (1998) Two isoforms of glutamate decarboxylase: why? Trends Pharmacol Sci 19:500-505 (Pubitemid 29008539)
45. Sohal VS, Zhang F, Yizhar O, Deisseroth K (2009) Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 459:698-702
46. Swerdlow NR, Braff DL, Taaid N, Geyer MA (1994) Assessing the validity of an animal model of deficit sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 51:139-154 (Pubitemid 24985903)
47. Todtenkopf MS, Benes FM (1998) Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain. Synapse 29:323-332 (Pubitemid 28328676)
48. Tomitaka S, Tomitaka M, Tolliver BK, Sharp FR (2000) Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK-801) injures pyramidal neurons in rat retrosplenial cortex. Eur J Neurosci 12:1420-1430 (Pubitemid 30224245)
49. Tomiyama M, Palacios JM, Cortés R, Vilaró MT, Mengod G (1997) Distribution of AMPA receptor subunit mRNAs in the human basal ganglia: an in situ hybridization study. Brain Res Mol Brain Res 46:281-289 (Pubitemid 27218311)
50. Tseng KY, Lewis BL, Hashimoto T, Sesack SR, Kloc M, Lewis DA, O'Donnell P (2008) A neonatal ventral hippocampal lesion causes functional deficits in adult prefrontal cortical interneurons. J Neurosci 28:12691-12699
51. Turner CP, DeBenedetto D, Ware E, Walburg C, Lee A, Stowe R, Swanson J, Lambert A, Lyle M, Desai P, Johnson R, Liu C (2009) MK801-induced activated caspase-3 exhibits selective colocalization with GAD67. Neurosci Lett 462:152-156
52. Vawter MP, Crook JM, Hyde TM, Kleinman JE, Weinberger DR, Becker KG, Freed WJ (2002) Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr Res 58:11-20 (Pubitemid 35287279)
53. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA (2000) Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gammaaminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 57:237-245 (Pubitemid 30140433)
54. Whittington MA, Traub RD (2003) Interneuron diversity series: inhibitory interneurons and network oscillations in vitro. Trends Neurosci 26:676-682 (Pubitemid 37415019)
55. Wong EH, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL (1986) The anticonvulsant MK-801 is a potent N-methyl-Daspartate antagonist. Proc Natl Acad Sci USA 83:7104-7108 (Pubitemid 16002378)
56. Woo TU, Walsh JP, Benes FM (2004) Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 61:649-657 (Pubitemid 38890797)